PRTA - Prothena GAAP EPS of $0.38 beats by $0.70 revenue of $84.87M
2023-11-02 16:14:22 ET
More on Prothena
- Prothena: Switching From 'Hold' To 'Buy' On Lead Alzheimer's Drug Promise
- Prothena (PRTA) Investor Presentation - Slideshow
- Prothena, BioVie among decliners after Biogen data for new Alzheimer’s therapy
- Prothena jumps on report company may explore a potential sale
- Seeking Alpha’s Quant Rating on Prothena
For further details see:
Prothena GAAP EPS of $0.38 beats by $0.70, revenue of $84.87M